Accuray Inc
A maker of radiation therapy machines used to treat cancer. Its best-known products are the CyberKnife, a robotic system that aims high-dose radiation at tumors from many angles, and the TomoTherapy system, which delivers radiation in a spiral pattern. Founded in 1990, the company traces its roots to Stanford University, where the CyberKnife's inventor, John Adler, developed the idea of pairing a robotic arm with a linear accelerator to target tumors anywhere in the body.
Granted 1.30M · Bought 250.0K
Granted 56.6K
Granted 50.3K
Granted 44.0K
Granted 56.6K
Granted 56.6K
Granted 56.6K
Granted 56.6K
Granted 56.6K
Granted 66.0K
Granted 83.7K
Granted 50.0K
Granted 37.5K
Bought 20.0K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Mayer Steven FDirector · 6 transactions | — | 1.55M | 1.30M | 250.0K | — |
| Whitters Joseph EDirector · 1 transaction | +9.3% | 667.7K | 56.6K | — | — |
| Chalke SandeepSVP, Chief Commercial Officer · 3 transactions | -11% | 419.8K | 50.3K | — | — |
| Pervaiz AliSVP Chief Financial Officer · 2 transactions | -3% | 352.9K | 44.0K | — | — |
| Hindman James M.Director · 1 transaction | +23.8% | 294.8K | 56.6K | — | — |
| Le Grand Anne BryceDirector · 1 transaction | +27.9% | 259.5K | 56.6K | — | — |
| Huss Beverly ADirector · 2 transactions | +30.2% | 244.0K | 56.6K | — | — |
| Nishimura MikaDirector · 1 transaction | +36.3% | 212.7K | 56.6K | — | — |
| Kill RobertDirector · 1 transaction | +53.3% | 162.8K | 56.6K | — | — |
| Scott Byron CDirector · 4 transactions | +36.4% | 162.7K | 66.0K | — | — |
| Peralta LeonelSVP, Chief Operations Officer · 2 transactions | — | 54.8K | 83.7K | — | — |
| Galbato ChanDirector · 1 transaction | — | 50.0K | 50.0K | — | — |
| Murphy Michael JohnVP, Corporate Controller · 2 transactions | — | 25.5K | 37.5K | — | — |
| La Neve Stephen R.CEO, Director · 1 transaction | — | 20.0K | — | 20.0K | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last year: +270.0K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.